Nifurtimox

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1188 publications

Chagas disease: An increasing clinical concern.

Chagas disease: An increasing clinical concern.

Journal: Nursing

Published: June 16, 2026

Purine derivatives as potential agents against Chagas disease: Ex vivo, in vitro, in silico evaluation, and identification of targets in Trypanosoma cruzi.

Purine derivatives as potential agents against Chagas disease: Ex vivo, in vitro, in silico evaluation, and identification of targets in Trypanosoma cruzi.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: April 20, 2026

5‑Nitrofuran-Semicarbazone Hybrids as Antitrypanosomal Agents: Structure-Activity Relationship and Nitroreductase Activation.

5‑Nitrofuran-Semicarbazone Hybrids as Antitrypanosomal Agents: Structure-Activity Relationship and Nitroreductase Activation.

Journal: ACS medicinal chemistry letters

Published: April 13, 2026

In Vivo Trypanocidal Activity of the Drug Disulfiram Combined with Benznidazole.

In Vivo Trypanocidal Activity of the Drug Disulfiram Combined with Benznidazole.

Journal: ACS infectious diseases

Published: March 31, 2026

In vitro profiling of Trypanosoma cruzi inhibitors identified from High throughput Screening and application to parasite painting.

In vitro profiling of Trypanosoma cruzi inhibitors identified from High throughput Screening and application to parasite painting.

Journal: International journal for parasitology. Drugs and drug resistance

Published: March 02, 2026

Biological evaluation of guanidines, bisguanidines, and their derivatives as anti-Trypanosoma cruzi agents.

Biological evaluation of guanidines, bisguanidines, and their derivatives as anti-Trypanosoma cruzi agents.

Journal: Bioorganic & medicinal chemistry letters

Published: February 16, 2026

Biological evaluation of guanidines, bisguanidines, and their derivatives as anti-Trypanosoma cruzi agents.

Biological evaluation of guanidines, bisguanidines, and their derivatives as anti-Trypanosoma cruzi agents.

Journal: Bioorganic & medicinal chemistry letters

Published: February 16, 2026

Asymptomatic Trypanosoma cruzi Infection Identified During Blood Donation Screening.

Asymptomatic Trypanosoma cruzi Infection Identified During Blood Donation Screening.

Journal: Cureus

Published: February 04, 2026

Using the Scaffold of FDA-Approved Drugs with Trypanocidal Activity to Identify New Anti-Trypanosoma cruzi Agents: An In Silico and In Vitro Approach.

Using the Scaffold of FDA-Approved Drugs with Trypanocidal Activity to Identify New Anti-Trypanosoma cruzi Agents: An In Silico and In Vitro Approach.

Journal: Molecules (Basel, Switzerland)

Published: January 31, 2026

An In Silico and In Vitro Approach Identified Potential Trypanothione Synthetase Inhibitors with Trypanocidal Activity.

An In Silico and In Vitro Approach Identified Potential Trypanothione Synthetase Inhibitors with Trypanocidal Activity.

Journal: Molecules (Basel, Switzerland)

Published: January 27, 2026

New insights for an old drug: difluoromethylornithine boosts the trypanocidal action of benznidazole on Trypanosoma cruzi in vitro and in vivo.

New insights for an old drug: difluoromethylornithine boosts the trypanocidal action of benznidazole on Trypanosoma cruzi in vitro and in vivo.

Journal: Frontiers in cellular and infection microbiology

Published: January 22, 2026

Identification of Novel Trypanosoma cruzi Cysteine Protease Inhibitors via Ligand-Based Virtual Screening of FDA-Approved Drugs with Trypanocidal Activity.

Identification of Novel Trypanosoma cruzi Cysteine Protease Inhibitors via Ligand-Based Virtual Screening of FDA-Approved Drugs with Trypanocidal Activity.

Journal: Diseases (Basel, Switzerland)

Published: January 15, 2026

Showing 1-12 of 1,188

Last Updated: 06/30/2026